Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter open-label self-controlled study of amino acid peritoneal dialysis solution
ChiCTR2500108808Phase 4Completed
- Sponsor
- Gaozhou People's Hospital
- Start
- Sep 2025
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amino acid peritoneal dialysis solution in end-stage kidney disease (ESKD) and protein-calorie malnutrition (PCM), sponsored by Gaozhou People's Hospital. Primary endpoints: Serum albumin at 6 months and Serum prealbumin at 6 months. Started Sep 2025; status: completed.
02
Drugs
amino acid peritoneal dialysis solution
03
Conditions
end-stage kidney disease (ESKD)protein-calorie malnutrition (PCM)
Beyond the preview
Go deeper on ChiCTR2500108808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108808.